Fundamental Analysis of NOVONIX LTD-ADR(NASDAQ:NVX) stock

Fundamental Rating

NVX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 126 industry peers in the Electronic Equipment, Instruments & Components industry. While NVX seems to be doing ok healthwise, there are quite some concerns on its profitability. NVX is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

NVX had negative earnings in the past year.

In the past year NVX has reported a negative cash flow from operations.

NVX had negative earnings in each of the past 5 years.

In the past 5 years NVX always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -19.46%, NVX is not doing good in the industry: 75.20% of the companies in the same industry are doing better.

NVX has a Return On Equity of -29.65%. This is in the lower half of the industry: NVX underperforms 75.20% of its industry peers.

		Industry Rank	Sector Rank
ROA	-19.46%
ROE	-29.65%
ROIC	N/A

ROA(3y)-14.15%

ROA(5y)-28.77%

ROE(3y)-18.11%

ROE(5y)-50.01%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NVX does not have a ROIC to compare to the WACC, probably because it is not profitable.

NVX has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, NVX has more shares outstanding

Compared to 1 year ago, NVX has a worse debt to assets ratio.

2.2 Solvency

NVX has an Altman-Z score of 0.61. This is a bad value and indicates that NVX is not financially healthy and even has some risk of bankruptcy.

NVX has a Altman-Z score of 0.61. This is in the lower half of the industry: NVX underperforms 73.60% of its industry peers.

NVX has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of NVX (0.44) is worse than 71.20% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF	N/A
Altman-Z	0.61

ROIC/WACCN/A

WACC9.31%

2.3 Liquidity

A Current Ratio of 6.15 indicates that NVX has no problem at all paying its short term obligations.

With an excellent Current ratio value of 6.15, NVX belongs to the best of the industry, outperforming 88.80% of the companies in the same industry.

A Quick Ratio of 5.94 indicates that NVX has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 5.94, NVX belongs to the top of the industry, outperforming 90.40% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.15
Quick Ratio	5.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.34%, which is quite impressive.

NVX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.47%.

NVX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.36% yearly.

EPS 1Y (TTM)34.34%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1.75%

Revenue 1Y (TTM)-17.47%

Revenue growth 3Y16.92%

Revenue growth 5Y27.36%

Sales Q2Q%-6.35%

3.2 Future

The Earnings Per Share is expected to decrease by -24.58% on average over the next years. This is quite bad

The Revenue is expected to grow by 67.12% on average over the next years. This is a very strong growth

EPS Next Y-2.11%

EPS Next 2Y-10%

EPS Next 3Y-4.29%

EPS Next 5Y-24.58%

Revenue Next Year40.44%

Revenue Next 2Y167.86%

Revenue Next 3Y179.22%

Revenue Next 5Y67.12%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVX. In the last year negative earnings were reported.

Also next year NVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as NVX's earnings are expected to decrease with -4.29% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-10%

EPS Next 3Y-4.29%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NVX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NOVONIX LTD-ADR

NASDAQ:NVX (10/23/2024, 8:00:03 PM)

2.08

-0.14 (-6.31%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap256.75M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-19.46%
ROE	-29.65%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.03

Health

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	6.15
Quick Ratio	5.94
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)34.34%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-2.11%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-17.47%

Revenue growth 3Y16.92%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

NOVONIX LTD-ADR (NVX)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens